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ABSTRACT 
Macrophages exert either beneficial or deleterious effects on tissue repair, depending on their 
activation/polarization state. They are crucial for adult skeletal muscle repair, notably by acting on 
myogenic precursor cells. However, these interactions have not been fully characterized. Here, we 
explored both in vitro and in vivo, in human, the interactions of differentially activated MPs with 
muscle precursor cells (MPCs) during adult myogenesis and skeletal muscle regeneration. We 
showed in vitro that through the differential secretion of cytokines and growth factors, pro-
inflammatory macrophages inhibited MPC fusion while anti-inflammatory macrophages strongly 
promoted MPC differentiation by increasing their commitment into differentiated myocytes and the 
formation of mature myotubes. Furthermore, the in vivo time course of expression of myogenic and 
macrophage markers was studied in regenerating human healthy muscle after damage. We observed 
that regenerating areas containing proliferating MPCs were preferentially associated with 
macrophages expressing pro-inflammatory markers. In the same muscle, regenerating areas 
containing differentiating myogenin positive MPCs were preferentially coupled to macrophages 
harbouring anti-inflammatory markers. These data demonstrate for the first time in human that 
macrophages sequentially orchestrate adult myogenesis during regeneration of damaged skeletal 
muscle. These results support the emerging concept that inflammation, through macrophage 
activation, controls stem cell fate and coordinates tissue repair. 
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INTRODUCTION  
Macrophages (MPs) are one of the main agents of innate immunity. They contribute to the host 
defence and phagocytosis of undesirable pathogens or tissue debris. As a consequence, MPs are 
mainly considered as "inflammatory" cells that are deleterious for the tissue and efforts are focused 
on decreasing or preventing their presence in the tissue. Indeed, several studies have shown that 
MPs enhance tissue damage. For example, MP depletion prevents or reduces the clinical signs of 
experimental autoimmune neuritis (1) or attenuates blood-nerve barrier disintegration during 
chronic nerve injury (2). MP depletion is also beneficial in the case of pulmonary and hepatic injury 
induced by toxicants (3). As the effects of MPs can be either beneficial or deleterious (4-6), 
depending on the concentration of MP supernatant used (for in vitro studies) or the time point when 
MP depletion is induced (in vivo models), it is clear that the actions of MPs are complex. In support of 
this, several studies have demonstrated beneficial roles for MPs in the context of tissue homeostasis 
and repair. For example, MP-secreted factors have been reported to promote the survival, 
regeneration and neurite extension of neurons (7-9), proliferation of hepatocyte (10) and skeletal 
muscle regeneration (11-13).  
The multiplicity of MP effects is likely due to their inflammatory profile or state of activation. 
Indeed, MPs adopt various inflammatory profiles depending on their environment. To help in 
understanding these various phenotypes, MPs have been classified into four main subtypes (14, 15). 
Pro-inflammatory or classically activated or M1 MPs are induced by TH1 cytokines. They secrete pro-
inflammatory cytokines and Reactive Oxygen Species (ROS) and exhibit microbicidal and tumoricidal 
activities. Alternatively-activated or M2a MPs are triggered by TH2 cytokines such a Interleukin (IL)4. 
These cells secrete a battery of specific markers (YM1, AMCase, Arginase 1 (Arg1)), are associated 
with extracellular matrix synthesis, angiogenesis, parasite containment and are observed during 
chronic fibrosis. Regulatory or M2b MPs are induced by a combination of TLR ligands and immune 
complexes and dampen inflammation. Anti-inflammatory or deactivated or M2c MPs are induced by 
anti-inflammatory compounds (e.g. IL10, glucocorticoids). They secrete anti-inflammatory cytokines 
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such as IL10 and Transforming Growth Factor (TGF)β. Harbouring different phenotypes, it is likely 
that the activated/polarized MPs exhibit various functions during innate immunity. Very few studies 
have explored their functions on progenitor cells. Interferon (IFN)γ- and Tumor Necrosis Factor 
(TNF)α-stimulated microglia blocks differentiation of adult neural progenitor cells while microglia 
activated by IL4 or low levels of IFNγ stimulates these neural progenitor cells toward 
oligodendrogenesis and neurogenesis, respectively (16). In skeletal muscle, we have shown that 
Lipopolysaccharide (LPS)/IFNγ-activated MPs stimulate myogenic cell proliferation while IL4 and IL10-
activated MPs support their differentiation (11). Although MP activation states have been clearly 
defined in vitro, the link between the activation states of MPs and their functions remains unknown 
for most in vivo situations. 
Adult skeletal muscle regeneration is an excellent paradigm of sterile inflammation with complete 
resolution. While the exact time course of human skeletal muscle regeneration has not been 
determined due to the restrictions of being able to sample human muscle a limited number of times 
using the biopsy technique, the time it takes for regeneration to be completed is known to vary 
depending on the nature of the experimental model employed. For example it has been shown that 
models of acute muscle damage employing neuromuscular electrical stimulation, in contrast to 
voluntary contractions, are required if the goal is to induce damage and regeneration, clearly 
observable by signs such as infiltration of macrophages into the myofibres, activation and 
proliferation of satellite cells, and the presence of myofibres positive for embryonic myosin (17-20). 
With regard to the time course of human muscle regeneration, studies aiming to examine the 
endpoint are sparse, with one recent study demonstrating ongoing regeneration of the myofibres 
and remodelling of the extracellular matrix as late as 30 days after a single bout of electrical 
stimulation (17). Several studies have demonstrated the presence of damaged fibres from a range of 
2 to 7 days post trauma (19-21), confirming the complexity of the sequence of events required for 
successful and complete regeneration of damaged skeletal muscle. From the few studies 
investigating muscle regeneration in humans, thus, it appears that biopsy sampling approximately 7 
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and 30 days post trauma would be suitable time points for studying processes of inflammation and 
satellite cell activity during skeletal muscle tissue repair.  
In vivo experiments in mouse have shown that MPs are very important for muscle repair (22). A 
sequential involvement of pro-inflammatory and alternatively activated/anti-inflammatory MPs has 
been delineated in this process. The first appearing pro-inflammatory MPs enter into the damaged 
muscle and a few days later, they convert into anti-inflammatory MPs (11). Meanwhile, the main 
muscle stem cells, satellite cells, undergo adult myogenesis through several sequential steps, each of 
which must be correctly completed to accommodate successful achievement of the subsequent 
steps. This process begins with the activation of the quiescent satellite cells on the myofibre by a 
damage signal. Activated myogenic precursor cells (MPCs) proliferate and it is believed that most of 
them enter into terminal myogenic differentiation, while a subset returns to quiescence to self-
renew the satellite cell pool (23). Adult myogenesis encompasses: i) activation of quiescent satellite 
cells and expansion of MPCs; ii) the commitment of MPCs into terminal differentiation. This requires 
cell-cycle withdrawal and expression of the myogenic programme including the expression of the 
myogenic regulatory factors myogenin and MRF4 and contractile proteins such as myosins; iii) the 
migration of the cells towards each other to establish cell/cell contacts and iv) the fusion of the cells 
into plurinucleated and contractile structures that form myotubes in vitro and myofibres in vivo. 
In the present work, we studied for the first time in human the relationship between the 
inflammatory profile of MPs and their regulatory role on the homeostasis of MPCs. We explored 
using human coculture in vitro which steps of adult myogenesis are controlled by differentially 
activated MPs and analysed the involvement of a series of MP-secreted effectors. In vivo, we 
investigated in parallel the kinetics of adult myogenesis and the presence of MP subtypes during 
human skeletal muscle regeneration. 
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MATERIALS AND METHODS 
Human MPC culture. Human MPCs were isolated from normal adult skeletal muscle sample 
according to the French legislation (protocol registered at the Agence de la Biomédecine in 2007 
"Interrelations entre les cellules souches adultes du muscle strié squelettique et les macrophages" 
and Cochin Hospital Cell Bank, Paris, agreement n° DC-2009-944). Cells were obtained and cultured 
as previously described (24) in HAMF12 medium (Gibco) containing 15% Foetal Bovine Serum (FBS) 
and were sorted before the first passage with anti-CD56 magnetic beads (Miltenyi Biotec) according 
to the manufacturer instructions. The purity of the cells was assessed for CD56 expression (555518 
BD Pharmingen) by flow cytometry (FC500 Beckman Coulter cytometer). 
Human MP culture. MPs were obtained from human Buffy-coat (purchased from Etablissement 
Francais du Sang according to INSERM-EFS agreement number C CPSL UNT n°09/EFS/024) as 
previously described (11, 25). MPs seeded in 12-well plates (36 000 cells/cm²) were 
activated/polarized for 2-3 days into M1 MPs with 1 µg/ml LPS and 10 ng/ml IFNγ, into M2c MPs with 
10 ng/ml IL10 and 80 ng/ml Dexamethasone, or into M2a MPs with 10 ng/ml IL4. Cells were then 
extensively washed (4 times) with serum-free medium to remove the effectors. Conditioned media 
were obtained by incubating MPs for 24h in advanced RPMI medium (Gibco) containing 0.5% FBS. 
Analysis of surface antigen expression was performed by flow cytometry. Activated MPs were 
detached by non enzymatic dissociation solution (Sigma-Aldrich) and gently scraped before being 
incubated with anti- CD16, HLA-DR, CD80, CD206 and CD163 antibodies (BD Pharmingen).  
In vitro myogenesis. MPCs were seeded on glass coverslips at 12000 cells/cm² and incubated with 
or without MP-conditioned medium for 3 days. In some experiments (Fig.1), MPCs were seeded on 
activated MPs. In other experiments (Fig.5), blocking antibodies were added at the time of addition 
of MP-conditioned medium. Antibody concentrations were chosen based on the ID50 according to 
the manufacturer and the concentration of secreted effectors by MPs, if known, from the literature: 
anti-TNFα 1/100 and 1/1000, anti-IL1β 1/200, anti-TGFβ 1/200, anti-IL13 1/100 (Abcam), anti-VEGF 
1/200, anti-IL6 1/100, anti-TWEAK 1/100 (R&D) (11, 26-28). 
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Commitment into myocytes. MPCs were seeded on glass coverslips at low density (500 
cells/cm²). In this condition, contact between MPCs was minimal, so they could not fuse. MP-
conditioned medium was then added and the cells were cultured for 72h.  
Myogenic fusion. MPCs were differentiated into myocytes for 3 days. These differentiated cells 
were seeded at high density: 50000 cells/cm², in 96 well plates. In this condition, the differentiation 
process and migration events were prevented. MP-conditioned medium was added and cells further 
cultured for 72h.  
Immunolabellings. Cells were labelled with anti-desmin (Ab32362 Abcam) and anti-myogenin 
(556358 BD Pharmingen) primary antibodies, revealed by Cy3- and biotinylated-conjugated 
secondary antibodies and streptavidin-DTAF (Jackson Immunoresearch, Vector Laboratories). Each 
experiment was repeated at least 3 times with different primary cultures and performed in triplicate. 
About 5-7 pictures (x20 magnification) were taken from the triplicates, in order that about 200-400 
(low cell density) or 1000 (high cell density) cells were counted per condition per experiment. 
Differentiation was measured as the number of myogenin positive nuclei divided by the total number 
of nuclei. The number of myotubes (cells containing 2 or more nuclei) was expressed as a percentage 
of the total cell number (Figs.1,5). Fusion index was the number of nuclei within myotubes divided by 
the total number of nuclei (Fig.4). Myotubes were also classified according to the number of 
myonuclei they contained and their distribution was expressed as a percentage of the total number 
of myotubes (Fig.4). 
MPC motility. MPC were seeded in 24 well plates at 1500 cells/cm², MP-conditioned medium was 
added and cells were imaged every 30 min for 16 h using a Zeiss Axiovert 200. Cell velocity was 
calculated using Image J software with the Manual Tracking plug-in. About 50 cells were analysed per 
condition per experiment.  
MPC migration. Migration was performed using two chambers Ibidi inserts (Ibidi GmbH). One 
chamber was filled with 4500 MPCs in growth medium. The second chamber was seeded with 25000 
MPs. MPs were activated for 3 days. The silicone walls of the device were removed and cells were 
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cultured in advanced RPMI medium containing 0.5% FBS. The gap between the two cell types was 
imaged at time 0 and 24 h. The distance that each cell had moved into the gap was analysed using 
Image J software. About 100 cells were analysed per condition per experiment.  
Human muscle samples. The human muscle biopsy sampling study was approved by the Regional 
Scientific Ethical Committees of Copenhagen in Denmark (Ref: HD-2008-074) and conformed to the 
standards set by the Declaration of Helsinki. Volunteers gave written informed consent before 
inclusion. Three young healthy untrained men (mean ± S.D. age 25 ± 2 yrs; height 182 ± 6 cm; weight 
80 ± 4 kg) participated in the study. Briefly, the exercise protocol utilized 10 sets of 20 maximal 
voluntary lengthening contractions of the quadriceps muscles, performed on an isokinetic 
dynamometer (KinCom KC125AP, Chattanooga group Inc.). Maximal percutaneous electrical 
stimulation was delivered to the vastus lateralis muscle during the contraction by a handheld 
stimulator (Elpha II 3000, Danmeter, Biotin). Muscle biopsies were obtained from the stimulated 
vastus lateralis on days 7 and 30 after the exercise protocol. A biopsy was also collected from the 
non-exercised leg on day 0 as a control. Muscle biopsies were collected under local anaesthesia (1% 
lidocaine) with a Bergstrom biopsy needle. After collection of the specimen, the fibres were aligned, 
embedded in Tissue-Tek (Sakura Finetek Europe) and frozen by immersion in isopentane, precooled 
by liquid nitrogen. Samples were stored at –80°C. For each biopsy, 10 serial transverse sections (10 
µm) were cut at –24°C using a cryostat and transferred onto SuperFrost Plus glass slides (Menzel-
Gläser).  
Human muscle immunolabellings. Serial sections of human muscle were treated for hematoxylin-
eosin (HE) staining or stained with antibodies raised against the following molecules: CD56 1/100 
(347740; Becton Dickinson), ki67 1/200 (CP249; Biocare Medical), myogenin 1/50 (F5D; 
Developmental Studies Hybridoma Bank), Pax7 1/100 (MO15020; Neuromics), CD68 1/100 (ab955 
Abcam), iNOS 1/25 (ab15323 Abcam), CD206 1/50 (ab8918 Abcam), CD163 1/500 (sc-20066 Santa 
Cruz), Arginase 1 1/25 (sc-18355 Santa Cruz), Cox2 1/25 (ab2372 Abcam), revealed by FITC- or Cy3-
conjugated secondary antibodies (Jackson Immunoresearch). Pictures were taken with a Zeiss Axio 
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observer.Z1. The slide was scanned with a tile scan camera which automatically collects overlapping 
focal stacks and processes them to reconstitute the entire muscle section. To confirm coexpression 
of CD68 labelling with pro- or anti-inflammatory markers, pictures were taken with an sp2 confocal 
microscope Leica TCS SP2 AOBS with a 1 µm depth. 
Scoring inflammation and myogenesis in human regenerating muscle. Calculations were made at 
day 7 post-electrostimulation. Post-injury regeneration was visible at the myofibre level. Discrete 
"regenerating areas" – corresponding to necrotizing/regenerating myofibres – which contained 
either CD56poski67pos or myogeninpos cells were quantified and evaluated for all the stainings. Zones 
containing numerous neighbouring regenerating myofibres were excluded to avoid confusion along 
the 10 serial sections. A total of 250 of regenerating areas was counted from 3 different biopsies. For 
each regenerating area, the number of cells positive for CD56, myogenin, ki67, CD68/iNOS, 
CD68/COX2, CD68/Arg1, CD206 and CD163 was evaluated. 
Statistics. All in vitro experiments were performed at least 3 times using independent MP and 
MPC primary cultures. In vivo analyses have been performed on 3 different subjects. Results are 
expressed as mean ± s.e.m. Means were compared using t-test or Anova for statistical analyses. P< 
0.05 was considered significant.  
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RESULTS 
Human MPC cultures were used in the in vitro study. More than 97% of these cells expressed 
CD56, a canonical marker for myogenic cells in human (Suppl.Fig1). After an expansion phase during 
which they proliferate, the majority of human MPCs enter into terminal differentiation and express 
myogenin (29). A subset of 15-20% of MPCs returns to quiescence to constitute a reservoir (29, 30). 
Differentiation is associated with migration of the cells into "areas" where fusion takes place (31). As 
previously shown, human MP activation triggers specific inflammatory profiles: M1 MPs secrete high 
levels of TNFα and IL1β (11). Flow cytometry analysis revealed that, as expected, M1 MPs expressed 
high levels of the co-stimulatory antigen CD80, M2a MPs expressed CD206 and M2c MPs expressed 
CD163. However, M2c MPs also expressed high levels of CD206 (Suppl.Fig1). 
Polarized MPs exert their effect on MPCs through soluble factors 
We checked whether the effects of activated/polarized MPs were triggered by soluble factors or 
whether contact between the two cell types was essential for the regulation of myogenesis. MPCs 
were either cocultured with MPs or treated with MP-conditioned medium for 3 days, and expression 
of myogenin and fusion of the cells were measured as final outcomes of in vitro myogenesis. Fig.1 
shows that M1 MPs slightly decreased cell fusion (p<0.05) while M2a MPs and M2c MPs stimulated 
both the expression of myogenin (Fig.1A,C) and myotube formation (both p<0.05) (Fig.1B,C). 
Myogenin expression (Fig.1A,C) and myotube formation (Fig.1B,C) by MPCs were similar in coculture 
and with MP-conditioned medium, indicating that MPs mainly exerted their effects on myogenesis 
through soluble factors. The following experiments were then performed with MP-conditioned 
media.  
M2a MPs and M2c MPs stimulate MPC commitment into myocytes 
Commitment into myocytes, which is the entry into terminal differentiation, was analysed 
through the expression of myogenin in low-density cell cultures, to prevent migration/fusion of the 
cells. M1 MP-conditioned medium did not alter the expression of myogenin by MPCs while M2a MP- 
and M2c MP-conditioned media strongly increased myogenin expression, by 2.7 and 4.2 fold, 
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respectively (p<0.05) (Fig.2). These data show that M2a MPs and M2c MPs stimulate the 
differentiation of MPCs into myocytes. 
M1 MPs stimulate MPC motility 
Fig.3A shows that a M1 MP-conditioned medium did not alter MPC motility compared to 
untreated cells. However, the speed of the cells was lower under M2a MP- and M2c MP-conditioned 
media (22 to 24% less, p<0.05). The median velocity was lower in cells treated with M2a MP- and 
M2c MP-conditioned medium (Fig.3B). Mean velocities of the cell populations above and below the 
median were also decreased (data not shown), indicating a decreased motility of the entire MPC 
population and not of a subset of MPCs. 
M1 MPs do not attract MPCs while they migrate towards MPCs 
Cell migration towards a gradient/other cell type was analysed in a double chamber silicone 
device (Fig.3C). Under M2a MPs and M2c MPs-conditioned media, MPCs displayed the same degree 
of migration as towards other MPCs, while their migration toward M1 MPs was much lower (-45%, 
p<0.05) (Fig.3D). Conversely, when examining MP migration, M1 MPs were strongly attracted by 
MPCs, compared to M2a MPs and M2c MPs (Fig.3E) (2.5 and 2 fold, respectively, p<0.05).  
M1 MPs inhibit MPC fusion 
Already differentiated myocytes (preventing the differentiation parameter) were plated at high 
density (preventing the migration parameter) in MP-conditioned media to evaluate fusion after 
desmin immunolabelling (Fig. 4A). Fusion index was strongly decreased in MPCs cultured with M1 
MP-conditioned medium (63%, p<0.05) (Fig.4B). The myotube distribution was significantly different 
under all MP conditions tested compared to MPC alone (p<0.05). In particular, M1 MP-conditioned 
medium inhibited the formation of large myotubes (75% inhibition for myotubes containing over 10 
nuclei, p<0.05) while the formation of small myotubes (3 to 5 nuclei) was unaffected (Fig.4C). As a 
whole, the fusion index of MPCs was not affected by M2a MP- and M2c MP-conditioned media 
(Fig.4B). However, the distribution of myotubes was significantly different from that of MPCs 
cultured alone (both p<0.05). M2c MP-conditioned medium stimulated the formation of large 
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myotubes (68% of increase for myotubes over 10 nuclei, p<0.05) (Fig.4C). Similarly, M2a MP-
conditioned medium stimulated the formation of large myotubes (52%, p<0.05) (Fig.4C). In both 
cases, the formation of small myotubes was not altered. These results suggest that activated MPs 
differentially control the formation of mature myotubes. 
Effectors secreted by activated MPs regulate in vitro myogenesis 
Some MP-released effectors are known or believed to have an impact on MPCs. However, the role 
of these effectors in the regulation of myogenesis through secretion by MPs has not been 
established. We tested the involvement of a series of 7 molecules in the regulation of myogenesis by 
MPs through the use of blocking antibodies. Blocking IL6 (Fig.5A) increased myotube formation (by 
38%, p<0.05) only in MPCs cultured with M1 MP-conditioned medium. Blocking IL1β similarly 
increased myotube formation only in MPCs cultured with M1 MP-conditioned medium (+49%, 
p<0.05) (Fig.5B). The blockade of VEGF (Fig.5C) increased myotube formation in MPCs treated with 
all MP-conditioned media, although the effect was more pronounced for M1 MPs (+58%, +20% and 
+26% for M1 MPs, M2a MPs and M2c MPs, respectively, all p<0.05). As TNFα is known to have 
differential effects on myogenesis depending on its concentration (32), we used two dilutions of 
blocking antibodies (Fig.5D). At a low dilution, anti-TNFα decreased myotube formation in M2a MP- 
and M2c MP-conditioned medium treated MPCs (30 and 31%, p<0.05) while it had no effect on M1 
MP-conditioned medium treated cells (Fig.5D, white bars). At a higher concentration, anti-TNFα still 
decreased myotube formation in M2a MP- and M2c MP-conditioned medium treated cells - to the 
same extent (p<0.05) - and increased myotube formation of MPCs incubated with M1 MP-
conditioned medium (+27% of fusion, p<0.05) (Fig.5D, gray bars). Blockade of the TNFα-family 
member TWEAK did not affect the formation of myotubes by MPCs in all conditions (Fig.5E). Anti-
IL13 antibodies induced an increase of myotube formation in MPCs cultured only in the presence of 
M1 MP-conditioned medium (+50%, p<0.05) (Fig.5F). Adding blocking anti-TGFβ antibodies 
significantly reduced the formation of myotubes in MPC cultures treated with M2a MP-and M2c MP-
conditioned media (-26 and -27%, respectively, p<0.05) (Fig.5G). Except for the TWEAK antibody, 
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none of these blocking antibodies affected the formation of myotubes by MPCs cultured alone 
(Fig.5H). Although it is known that MPCs synthesize some of these cytokines and growth factors (33, 
34), MPs secrete much higher levels of these compounds (11, 26). These results show that effectors 
differentially secreted by activated MPs regulate myotube formation according to the state of 
activation of MPs. 
During in vivo human muscle regeneration, MPs sequentially express pro and anti-inflammatory 
markers and are associated with proliferating and differentiating MPCs, respectively 
To explore inflammation during in vivo human muscle regeneration, we used a protocol 
combining lengthening c ntractions and electrostimulation (20). This resulted in myofibre damage, 
and the kinetics of tissue repair can be followed during the ensuing muscle regeneration. Suppl.Fig.2 
shows that in normal untreated human muscle (day 0), CD56 positive cells (CD56pos) were observed 
throughout the muscle, at the normal place of satellite cells, while no staining was observed for the 
embryonic form of myosin heavy chain, which is a characteristic of regenerated/regenerating 
myofibres (35). On day 7 after the damage induction, the myogenic marker CD56 stained numerous 
areas while embryonic myosin heavy chain stained several regenerating myofibres (Suppl.Fig.2, day 
7). These areas associated with CD56pos cells and young new myofibres were observed in regions of 
damaged myofibres and where regeneration took place. These regions, which we called regenerating 
areas, were distributed throughout the muscle biopsy cross section (Suppl.Fig.2, day 7). On day 30 
after damage, the muscle had recovered its normal histology, except for very rare myofibres with a 
centrally located myonucleus (Suppl.Fig.2, day 30). That the dynamic processes of damage and 
regeneration can be followed so clearly in this model makes it suitable for studying the relationship 
between MP activation and myogenesis in vivo. 
To assess MP activation in vivo, we analysed on serial sections the expression of various pro and 
anti-inflammatory markers, together with myogenic markers, during normal human skeletal muscle 
regeneration. Pax7 is a transcription factor expressed by quiescent and cycling, but not 
differentiating, MPCs. CD56 is expressed by quiescent, cycling, differentiating MPCs and young 
Page 14 of 42
ScholarOne Support: (434) 964-4100
Stem Cells
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
15 
 
regenerated myofibres. Myogenin is a transcription factor only expressed by differentiating 
myogenic cells. In human, CD68 is believed to widely label MPs while expression of CD206 and CD163 
has been associated with anti-inflammatory phenotypes. When expressed by MPs, iNOS and 
cyclooxygenase 2 (COX2) are pro-inflammatory markers while Arg1 is expressed by M2a MPs (14, 15). 
In normal muscle at steady state, almost no CD56
pos
 cells were ki67
pos
 indicating that they were 
quiescent (Fig.6, d0), as previously reported (18). As expected, no labelling for myogenin was 
observed (data not shown). Few cells were observed in the interstitial space that were positive for 
CD68, CD206 or CD163; no positivity was observed for iNOS, COX2 or Arg1 (Fig.6, d0). At day 7 after 
damage, numerous regenerating areas were present, containing proliferating cells (ki67posCD56pos) 
and/or differentiating cells (myogenin
pos
) (Fig.6, d7, Fig.7). The vast majority (over 80%) of the 
regenerating areas was associated with MPs that were positive for pro- and for anti-inflammatory 
markers. Less than 20% of the regenerating areas were associated with only one type of MPs: 17% 
contained MPs expressing only anti-inflammatory markers while 0.4% to 2% was associated with only 
pro-inflammatory MPs (when considering 3 and 2 markers, respectively). This suggests that MPs 
expressing pro- and anti-inflammatory markers coexisted in the same regenerating areas. To analyse 
whether early and later regenerating areas were preferentially associated with different types of 
MPs, they were divided according to the absence (about 28% of the total regenerating areas) or the 
presence (about 72%) of myogeninpos cells, independently of the number of myogeninpos cells. The 
number of MPs per myofibre did not differ between myogenin
pos
- and myogenin
neg
- containing 
regenerating areas. An MP/MPC ratio of 2.5 ± 0.7 was found in regenerating areas, the median being 
1.8 (the absolute range was from 0 to 12 MPs/area). When the regenerating areas were divided 
according to the presence or absence of myogeninpos cells, MP inflammatory markers segregated 
(Fig.6, d7, Fig.7). Pro-inflammatory markers such as iNOS and COX2 were expressed by more MPs in 
regenerating areas containing only myogenin
neg
 cells compared to those containing at least one 
myogeninpos MPC: 51.3 vs. 22.2 and 44.6 vs. 18.6%, respectively (p<0.05) (Fig.6, d7, Fig.7). 
Conversely, Arg1-expressing MPs were more numerous in regenerating areas containing myogenin
pos
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MPCs, compared to those without differentiating MPCs: 52.8 vs. 30.9% (p<0.05) (Fig.6, d7, Fig.7). The 
actual expression of iNOS, COX2 and Arg1 by CD68 MPs was assessed by confocal microscopy (Fig.7). 
Immunostainings showed that most of the regenerating areas contained MPs expressing CD206 and 
CD163. However, regenerating areas containing myogeninpos MPCs were associated with 1.8 fold 
more CD206
pos
 MPs and CD163
pos
 MPs (p<0.05) (Fig.6, d7, Fig.7). It has been shown that murine 
myogenic cells express CD206 (36). Colabelling of regenerating human muscle with CD68 and CD206 
showed that almost all CD206
pos
 cells observed in the regenerating areas were costained with CD68 
indicating their macrophagic origin (Suppl. Fig.3). Thirty days after damage, no cycling or 
differentiating cells were observed (Fig.6, d30). With regard to the untreated muscle at d0, few MPs 
expressing CD68, CD206 or CD163 were observed between the myofibres, and they did not express 
iNOS or COX2. Some MPs expressed Arg1 (Fig.6, d30). Taken together, these data reveal that 
different MP subsets are preferentially associated with areas containing proliferating or 
differentiating MPCs.  
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DISCUSSION 
The present study shows for the first time in human that MPs differentially act on MPCs 
depending on their activation/polarization state. They exert these trophic roles through the secretion 
of a series of cytokines and growth factors, thereby controlling the fate of the muscle progenitors at 
each step of in vitro myogenesis. We also show for the first time in human that these in vitro 
activated MPs correspond to MP subsets in vivo. Indeed, during human muscle regeneration, 
regenerating areas are first preferentially associated with MPs bearing pro-inflammatory markers. 
Then, at the time of myogenic differentiation, MPs expressing anti-inflammatory markers are 
preferentially found in the regenerating areas. 
Trophic activities for MPs have recently emerged in various contexts of tissue development, 
morphogenesis and angiogenesis (37, 38). In normal adult tissues, recent advances have been made 
in identifying supportive roles for MPs in stem cell homeostasis. MPs promote erythroblast survival 
and differentiation through very late activation antigen 4 (VLA-4) and CD163 (39-41). MPs support 
stem cell homeostasis in the bone marrow, and in intestinal and mammary epithelia (42-45). In the 
nervous system, microglia rescues neurogenesis in neural stem cells by the secretion of neurogenic 
factors (46). MPs deliver anti-inflammatory cues beneficial to spinal cord recovery (47). They secrete 
TGFβ which promotes oligodendrocyte differentiation and myelinogenesis (48). Microglia activated 
by pro-inflammatory cues block neural progenitor differentiation while IL-4-activated microglia 
stimulates the formation of oligodendrogenesis, possibly through the production of IGF-1 (16, 49). In 
skeletal muscle, we have shown in vitro that MPs rescue MPCs from apoptosis and stimulate their 
growth and proliferation through a panel of secreted and membrane-bound effectors (25, 33).  
In our in vitro coculture system, based on a 1:3 MP:MPC ratio, we here showed that MPs mainly 
exerted their effects on myogenesis through the secretion of soluble factors. We have previously 
shown in vitro that M1 MPs stimulate MPC proliferation while M2a MPs and M2c MPs do not (11). 
Here we explored each step of in vitro myogenesis using an experimental setup that allows for 
analysis of each step independently of the others: commitment into myocyte, migration and fusion 
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(36). During in vitro myogenesis, MPCs migrate to the injured area and then toward each other in 
order to form myotubes. Differentiating and differentiated MPCs express a wide range of chemokine 
receptors that bind to chemokines in a redundant way (50). Activated MPs have been shown to 
secrete specific panels of chemokines (14, 15) and likely other attracting molecules. Chemotaxis is a 
global integrated cell response to signalling by several individual receptors. Therefore, it is difficult to 
decipher which signals secreted by MPs govern MPC motility and chemotaxis. However, our results 
present a new property of human MPs in the regulation of progenitor motility. Anti- and M2a MPs 
were observed to decrease the motile properties of MPCs and were better attractants for MPC 
directional migration. We have previously shown in vitro that MPCs attract circulating monocytes 
(33). It is therefore tempting to propose, knowing that M1 MPs are the first to enter the damaged 
muscle in mouse (11), that monocyte-derived M1 MPs have a great migratory capacity toward MPCs 
at the beginning of muscle regeneration. It can be hypothesised that these M1 MPs would maintain 
MPC migratory capacities thus preventing fusion from occurring too early, a high migratory speed 
being detrimental for good fusion (51). M2a MPs and M2c MPs would further attract MPCs, decrease 
their motility, thus favouring contact between cells, and deliver pro-differentiating cues. Further 
analyses are required to confirm these hypotheses. 
Myogenic commitment into myocytes is the expression of the myogenic programme after cell 
cycle withdrawal and precedes fusion, which is the last step of in vitro myogenesis. In all the 
functional assays we tested in vitro, M2a MPs and M2c MPs displayed opposing effects to those of 
M1 MPs. M1 MPs inhibited MPC fusion, particularly the formation of large myotubes while M2a MPs 
and M2c MPs strongly stimulated the commitment of MPCs into myocytes and promoted the 
formation of large myotubes. Our results suggest that the formation of nascent myotubes is not 
controlled by MP-conditioned media. Most of the molecular systems involved in prefusion migration 
and myocyte fusion are transmembrane proteins and a few soluble effectors have been identified 
(52). Among them IL4 is involved in the formation of mature myotubes in mouse (53). IL4 production 
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by lung MPs has been associated with the presence of M2a MPs (54, 55). IL4 may, therefore, be one 
of the effectors of the stimulation of fusion by M2a MPs and M2c MPs. 
Few molecules that can account for the effects of MPs on muscle precursors are known. Recent 
work in mouse showed that G-CSF is beneficial to skeletal muscle regeneration by stimulating MPC 
proliferation (56). This study did not explore which cells were the source of G-CSF. However, MPs 
secrete G-CSF, particularly M1 MPs, and G-CSF has been shown to be associated with inflammation 
and activation by Th-1 cytokines (57, 58). Exploring the role of CCR2 expressed by MPs, Lu et al. (59) 
have shown that MPs are likely to be the main source of IGF-1 in regenerating muscle; they further 
showed that the intramuscular Ly6Cneg MP subset, which presents an anti-inflammatory profile, 
expresses high levels of IGF-1, which promotes muscle repair. Here we show the involvement of 
several cytokines and growth factors in the regulation of myogenesis by activated MPs. The pro-
inflammatory cytokines IL6 and IL1β are mainly secreted by M1 MPs compared to M2a MPs and M2c 
MPs (11, 26), and blocking IL6 or IL1β affected only this MP subtype by increasing the formation of 
myotubes. Accordingly, IL6 has a proliferative effect on MPCs (60, 61), while IL1β has been shown to 
induce IL6 production (62) and to reduce myogenic differentiation (63, 64). TNFα is also produced in 
greater amounts by M1 MPs (11, 26). The effects of TNFα inhibition depended on the concentration 
of antibodies used, in accordance with the dose-dependent effect of TNFα on muscle cell 
proliferation (32). At low concentrations, TNFα stimulates myogenic differentiation (32). Accordingly, 
decreased myotube formation was observed upon TNFα inhibition of M2a MPs and M2c MP-
conditioned media, which contain low levels of TNFα. Conversely, high levels of TNFα stimulate 
myogenic cell proliferation (32) and M1 MPs increased myotube formation when the cytokine was 
completely inhibited by blocking antibodies. VEGF stimulates MPC growth (65) and differentiation 
(66, 67). M1 MPs produce more VEGF than M2a MPs and M2c MPs (26). However blocking VEGF 
induced an increase in myotube formation in all conditions, suggesting that the effect of VEGF 
on MPCs is mainly on cell growth. IL13 regulates the secondary recruitment of reserve cells into 
myotubes, particularly on IGF-1 stimulated human cells (68) and increases fusion into myotubes (69). 
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Unexpectedly, blocking IL13 induced increased myotube formation in MPCs cultured with M1 MP-
conditioned medium, suggesting that IL13 participates in the non-differentiating property of M1 
MPs. TGFβ is expressed to a greater extent by M2a MPs and M2c MPs (11). TGFβ inhibits cell 
myogenesis at the time of differentiation (70-72) while it decreases cell growth and activates 
myogenesis when added to proliferating myoblasts (73). Here, TGFβ participated in the pro-
differentiating cues delivered by M2a MPs and M2c MPs to MPCs since its blockade reduced 
myotube formation in these two conditions. These results identify an initial series of effectors 
differentially secreted by activated MPs which are involved in the regulation of in vitro myogenesis 
through their effects on MPCs.  
It is likely that the MP activation states used for in vitro studies are not fully representative of MP 
subsets found in vivo (14, 74). Therefore, we followed, to our knowledge for the first time in human, 
the regeneration of skeletal muscle in muscle biopsies obtained from healthy young men who had 
performed maximal lengthening contractions of the quadriceps muscles – a model that has 
previously been used in many human studies of muscle damage (21, 75-77). However, not all studies 
using this model have observed damage in muscle biopsies collected in the days after exercise (20, 
78). Furthermore, in a previous study (20), electrical stimulation was reported to result in greater 
muscle damage than voluntary contractions. In light of this, and in order to ensure initiation of 
damage and regeneration processes, we increased the load delivered to the muscle by electrically 
stimulating the vastus lateralis muscle while the subject was contracting the muscle voluntarily. 
Analysis of muscle biopsies collected before and after this stimulus to the muscle enables distinct 
muscle regenerative events to be followed clearly in humans in vivo.  
We investigated the expression of a series of MP markers, together with myogenic markers, 
during the time course of regeneration in human muscle. The first lesson from this study is that MP 
subsets cannot definitively be identified by a sole marker, and that multiple labellings are required to 
attempt to define MP subsets in vivo. We analysed the expression of iNOS, COX2 and Arg1 by CD68pos 
cells. Colabelling and analysis at the single cell level are necessary since many other cells, including 
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endothelial cells, interstitial cells and myogenic cells also express these molecules (79-81). CD206 and 
CD163 are considered as markers for anti-inflammatory subsets (see Suppl. Fig.1). Careful 
examination of the immunostainings showed that several levels of fluorescence brightness were 
observed for these markers (data not shown), in accordance with their increased expression by anti-
inflammatory MPs (82, 83). The second lesson from this series of experiments is conceptual. Our 
results clearly show that, according to the 6 markers used here to identify MPs in vivo, several 
subsets of MPs are present in the same areas at the same time. These results argue against the 
overly simplistic view that a biological event is associated with one type of MPs. Also found in the 
same regenerating areas were cycling myogenic cells (CD56pos or Pax7pos ki67pos) together with 
differentiating cells (myogenin
pos
). Therefore, although general conclusions regarding the time course 
of some major biological events can be drawn, one must keep in mind that these events spatially and 
temporally overlap.  
We present here the first time course of analysis of inflammation during human skeletal muscle 
regeneration. Our results confirm that both in normal muscle and once regeneration is completed, 
almost no MP is present in the muscle parenchyma. Regenerating areas are associated with MPs, the 
vast majority (over 80%) being associated with MPs expressing pro and anti-inflammatory markers. 
However, despite this complex situation, our analysis depicts a time course of inflammation during 
human skeletal muscle repair that resembles what has been observed in mouse (11, 84). When 
analysing regenerating areas on the basis of whether they did or did not contain myogenin
pos
 cells, a 
segregation in MP distribution was observed. Regenerating areas that contained only myogeninneg 
cells were preferentially associated with MPs expressing pro-inflammatory markers. Conversely, 
regenerating areas containing at least one myogeninpos cell were preferentially associated with MPs 
expressing anti-inflammatory markers. The evidence of such localisation indicates privileged 
interactions between the two cell types and argues for a synchronous regulation of adult myogenesis 
and inflammation during muscle repair. The distinction between M2a MPs and M2c MPs during 
muscle regeneration is not yet clear. It is likely that the so-called "anti-inflammatory" subset(s) 
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include(s) some MPs that stimulate matrix remodelling and deposition (thus resembling M2a MPs). 
Perdiguero et al. (84) showed that 3 MP subsets are successively present during muscle repair: 
inflammatory MPs, anti-inflammatory MPs, and a deactivated MP subset associated with the last 
steps of muscle repair. "Canonical" M2a MPs have been identified under very specific conditions, i.e. 
parasitic challenge; it is therefore not known whether this type of MPs may be also - even transiently 
- present during normal tissue repair. 
 
CONCLUSION 
Combining our in vivo and in vitro data indicates that human skeletal muscle regeneration is 
sequentially associated with several MP subsets. Furthermore, we provide evidence of new functions 
of MPs in the coordinated regulation of MPC fate during muscle repair. In vivo analyses in a model of 
skeletal muscle regeneration in the healthy adult revealed that regenerating areas at the time of 
MPC proliferation are associated with M1 MPs, while in vitro experiments accordingly showed that 
M1 MPs migrate towards MPCs, stimulate their proliferation and prevent premature differentiation 
through the secretion of IL-6, IL1-β, high TNFα, VEGF and IL-13. In vivo immunostainings showed that 
later, at the time of terminal differentiation, regenerating areas are associated with M2c MPs and/or 
M2a MPs. In line with this, in vitro experiments showed that M2a MPs and M2c MPs attract MPCs, 
and promote in vitro myogenesis by stimulating their commitment into myocytes and the formation 
of mature myotubes, through the secretion of TGFβ and low TNFα. Thus, MPs orchestrate an 
effective skeletal muscle repair process by finely tuning the sequential steps of adult myogenesis. 
These results strengthen the emerging concept that inflammation regulates stem cell homeostasis. 
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FIGURE LEGENDS 
Figure 1. MPs exert their effect on in vitro myogenesis through the delivery of soluble factors. 
MPCs were cocultured with M1 MPs, M2a MPs or M2c MPs (black bars) or were cultured with or 
without conditioned medium from the same activated MPs (white bars) and grown for 3 days. MPCs 
were immunolabelled for desmin and myogenin and the number of desmin
pos
 myogenin
pos
 (A) and of 
myotubes (B) was calculated as a percentage of desminpos cells. Results are means ± s.e.m. of 3 
independent experiments. (C) Examples of desmin (red) and myogenin (green) labellings in MPCs 
cocultured with MPs or treated with MP-conditioned-media for 3 days. Blue = Hoechst. Bar=50µm. *: 
p<0.05 vs. M1 MPs, #: p<0.05 vs. None. 
Figure 2. Effects of MPs on MPC commitment into myocytes. MPCs were cultured at low density 
with or without conditioned medium from M1 MPs, M2a MPs or M2c MPs for 3 days. (A) MPCs were 
immunolabelled for desmin (red) and myogenin (green) (blue=Hoechst). Bar=50 µm. (B) The number 
of myogeninpos nuclei is expressed as a percentage of total nuclei. Results are means ± s.e.m of 3 
independent experiments. *: p<0.05 vs. None and vs. M1 MPs. 
Figure 3. Effects of MPs on MPC motility and migration. (A,B): MPCs were cultured with or 
without conditioned medium from M1 MPs, M2a MPs or M2c MPs and observed for 16 h. Individual 
cell trackings were followed with Image J software and the velocity for each cell was calculated. (A) 
Mean velocity of whole MPC population is expressed in µm/min. (B) Boxes represent the velocity of 
total cell population (min to max), with the median. Results are means ± s.e.m of 3 independent 
experiments. *: p<0.05 vs. None and vs. M1 MPs. (C-E): MPCs and MPs (M1 MPs, M2a MPs or M2c 
MPs) were cultured in two-chamber devices (C, here as an example, MPCs and M2a MPs) so the two 
cell types faced each other, allowing migration towards each other over a 24 h period. Pictures were 
taken at 0 and 24 h. A virtual line was drawn on the picture at the cell front at time 0 and copied to 
the picture at time 24 h. Individual cell migration was calculated from this line. Individual cell 
migration of MPCs towards activated MPs (D) and of MPs towards MPCs (E) is expressed in µm. 
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Results are means ± s.e.m of 4 independent experiments. *: p<0.05 vs. MPCs in D and vs. M1 MPs in 
E. 
Figure 4. Effects of MPs on MPC fusion. Differentiated MPCs (myocytes) were cultured at high 
density with or without conditioned medium from M1 MPs, M2a MPs or M2c MPs for 3 days. (A) 
MPCs were immunolabelled for desmin (red) (blue=Hoechst). Bar=50 µm. Myotubes were counted 
and classified according to their number of nuclei. (B) Fusion index is expressed in %. (C) Each class of 
myotubes is expressed as percentage of total myotubes. Results are means ± s.e.m of 3 independent 
experiments. *: p<0.05 vs. None. 
Figure 5. MPs exert their effect through a series of secreted effectors. MPCs were cultured with 
or without conditioned medium from with M1 MPs, M2a MPs or M2c MPs in the absence (black 
bars) or the presence (white bars) of blocking antibodies directed against IL-6 (A), IL-1β (B), VEGF (C), 
TNFα (D, antibody was used at 1/1000 (white bars) and 1/100 (gray bars), TWEAK (E), IL-13 (F), and 
TGFβ (G). Three days later, MPCs were immunolabelled for desmin and the number of myotubes was 
calculated as a percentage of desmin
pos
 cells. (H) MPCs were incubated without MP-conditioned 
medium in the presence of the blocking antibodies. Results are means ± s.e.m of at least 3 
independent experiments. *: p<0.05 vs. control (medium without antibodies, black bars). 
Figure 6. Kinetics of myogenic and MP markers during human skeletal muscle regeneration. 
Serial sections from control (d0) and electrostimulated human muscle at day 7 and day 30 after 
electrostimulation were stained for various myogenic (CD56, myogenin) and MP (CD68, CD206, 
CD163) markers. ki67 labels cycling cells, laminin labels the basal membrane, COX2, iNOS and Arg1 
expression is associated with various states of MP activation. Arrows indicate regenerating areas that 
do not contain myogeninpos cells; arrowheads indicate regenerating areas that contain at least one 
myogeninpos cell. Bar=50 µm. Pictures are representative of 3 independent experiments. 
Figure 7. Association of differentially activated MPs with regenerating areas during skeletal 
muscle regeneration in human. Serial sections of human muscle on day 7 after electrostimulation 
were stained for various myogenic (Pax7, CD56, myogenin) and MP (CD68, CD206, CD163) markers. 
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ki67 labels cycling cells; laminin labels the basal membrane; COX2, iNOS and Arg1 expression is 
associated with various states of MP activation. Arrows indicate regenerating areas that do not 
contain myogenin
pos
 cells; arrowheads indicate regenerating areas that contain at least one 
myogeninpos cell. Bottom panel: confocal analysis was performed to assess colocalisation of COX2, 
iNOS and Arg1 in CD68
pos
 cells. Bar=50 µm. Histograms on the right panel display the percentage of 
iNOSpos (A), COX2pos (B), Arg1pos (C) CD68pos cells in regenerating areas containing (w myog+) or not 
containing (w/o myog+) myogenin
pos
 cells. D and E show the number of CD206
pos
 (D) and CD163
pos
 (E) 
cells in regenerating areas containing (w myog+) or not containing (w/o myog+) myogeninpos cells. 
Results are means ± s.e.m of 3 independent experiments. 
Supplemental Figure 1. Flow cytometry analysis of MPCs and MPs. (A) Primary human MPCs 
were cultured and sorted before passage 1 with anti-CD56 magnetic beads and analysed by flow 
cytometry for CD56 expression (B). Human MPs were activated as M1 MPs, M2a MPs or M2c MPs 
and analysed for their expression of pan-macrophagic markers (CD14, HLA-DR) and markers 
associated with the pro-inflammatory state (CD80), alternative activation state (CD206) and anti-
inflammatory state (CD163). Results are means ± s.e.m of 3 independent experiments. 
Supplemental Figure 2. Model of in vivo human muscle regeneration. Vastus lateralis muscle was 
subjected to voluntary lengthening contractions and electrostimulation. The contralateral leg was 
biopsied at day 0. Then the damaged leg was biopsied at day 7 and 30 after damage induction. 
Histological sections were stained for HE, and were immunolabelled for laminin, embryonic myosin 
heavy chain or CD56 (blue = Hoechst). Bar=50 µm. Pictures are representative of 3 independent 
experiments. 
Supplemental Figure 3. In vivo costaining of CD68 and CD206. Sections from human muscle day 7 
after electrostimulation were stained for CD68 (green) and CD206 (red) markers. Most of the 
CD206
pos
 cells were also labelled for CD68, indicating that they were macrophages. Few cells outside 
the regenerating area were positive for CD206 alone and were likely myogenic or satellite cells 
(arrows). Bar=50 µm.  
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